[Special Stock] Overseas Business Expansion Expectations... Pulmuone Up 6%

Pulmuone is showing strong performance in early trading due to growth expectations, as its sales proportion is increasing mainly overseas, including in the United States.

As of 9:30 AM on the 19th, Pulmuone is trading at 15,400 KRW, up 900 KRW (6.21%) from the previous trading day.

Pulmuone's sales for 2024 reached 3.2137 trillion KRW, a 7% increase compared to the previous year, and operating profit rose 47% to 91 billion KRW, marking a record high performance. Notably, the overseas business centered on the United States showed remarkable growth.

Pulmuone's key strategies for 2025 are also aligned with its overseas business. In the U.S., where market interest is high, its main products are showing steady growth in the business-to-consumer (B2C) market, while the company plans to actively enter the business-to-business (B2B) market focusing on tofu.

Regarding this, NH Investment & Securities analyst Ju Young-hoon said, "Pulmuone operates a local factory in the U.S., which is an advantage as it is exempt from tariff issues imposed by the Trump administration. Although the short-term contribution to earnings may not be significant, the direction of expanding global business could serve as a momentum for the stock price."

This content was produced with the assistance of AI translation services.